Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease
作者:Zhipei Sang、Keren Wang、Pengfei Zhang、Jian Shi、Wenmin Liu、Zhenghuai Tan
DOI:10.1016/j.ejmech.2019.07.021
日期:2019.10
A series of novel chalcone derivatives was designed, synthesized and evaluated as multifunctional agents for the treatment of AD. Among of these synthesized compounds, compound TM-2 was a selective BuChE inhibitor (IC50 = 2.6 μM) and selective MAO-B inhibitor (IC50 = 5.3 μM), which were supported by docking study. Compound TM-2 also showed good antioxidant activity, and was a selective metal chelator
设计,合成和评价了一系列新颖的查耳酮衍生物,将其作为治疗AD的多功能药物。在这些合成的化合物中,化合物TM-2是选择性BuChE抑制剂(IC 50 = 2.6μM)和选择性MAO-B抑制剂(IC 50 = 5.3μM),这受到对接研究的支持。化合物TM-2还显示出良好的抗氧化活性,并且是选择性的金属螯合剂以及神经保护剂。此外,化合物TM-2能抑制显著自诱导和Cu 2+诱导的阿β 1-42与70.2%和80.7%的抑制率聚合,分别与可能分解的Cu 2+诱导的阿β 1-42聚集(73.5%),进一步的TEM图像中观察到提供合理的解释。此外,化合物TM-2表现出良好的PAMPA-BBB渗透性,并符合Lipinski的5法则。此外,化合物TM-2在体内测定中对东pol碱诱导的记忆障碍表现出预认知作用。因此,化合物TM-2可能是治疗AD的有前景的多功能命中化合物,并且进一步的结构优化正在进行中。